Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

S P Mulligan

Showing results (11-20 of 19) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 19 results.
Nucleosides, Nucleotides & Nucleic Acids|July 5, 2008
Fludarabine induces differential expression of proteins in human leukemia and lymphoma cellsS Henrich, S Gez, B Crossett, et al.
Blood|September 1, 1990
B-ly-7, a monoclonal antibody reactive with hairy cell leukemia, also defines an activation antigen on normal CD8+ T cellsS P Mulligan, P Travade, E Matutes, et al.
European Journal of Applied Physiology and Occupational Physiology|January 1, 1995
The effects of altered exercise distribution on lymphocyte subpopulationsC R Host, K I Norton, T S Olds, et al.
Cancer Research|June 5, 2001
Immunophenotyping of leukemias using a cluster of differentiation antibody microarrayL Belov, O de la Vega, C G dos Remedios, et al.
British Journal of Haematology|May 8, 1999
Transendothelial migration of lymphocytes in chronic lymphocytic leukaemia is impaired and involved down-regulation of both L-selectin and CD23J R Chen, B J Gu, L P Dao, et al.
British Journal of Haematology|October 29, 1998
B-cell chronic lymphocytic leukaemia with CD8 expression: report of 10 cases and immunochemical analysis of the CD8 antigenS P Mulligan, L P Dao, S E Francis, et al.
British Journal of Haematology|July 1, 1995
The myelodysplastic syndromes: an analysis of prognostic factors in 226 cases from a single institutionI Cunningham, S J MacCallum, M D Nicholls, et al.
Blood Cancer Journal|February 4, 2017
Ibrutinib in previously treated chronic lymphocytic leukemia patients with autoimmune cytopenias in the RESONATE studyM Montillo, S O'Brien, A Tedeschi, et al.
Leukemia|June 9, 2017
Extended follow-up and impact of high-risk prognostic factors from the phase 3 RESONATE study in patients with previously treated CLL/SLLJ R Brown, P Hillmen, S O'Brien, et al.
Pageof 2

Showing results (11-20 of 19) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 19 results.
Nucleosides, Nucleotides & Nucleic Acids|July 5, 2008
Fludarabine induces differential expression of proteins in human leukemia and lymphoma cellsS Henrich, S Gez, B Crossett, et al.
Blood|September 1, 1990
B-ly-7, a monoclonal antibody reactive with hairy cell leukemia, also defines an activation antigen on normal CD8+ T cellsS P Mulligan, P Travade, E Matutes, et al.
European Journal of Applied Physiology and Occupational Physiology|January 1, 1995
The effects of altered exercise distribution on lymphocyte subpopulationsC R Host, K I Norton, T S Olds, et al.
Cancer Research|June 5, 2001
Immunophenotyping of leukemias using a cluster of differentiation antibody microarrayL Belov, O de la Vega, C G dos Remedios, et al.
British Journal of Haematology|May 8, 1999
Transendothelial migration of lymphocytes in chronic lymphocytic leukaemia is impaired and involved down-regulation of both L-selectin and CD23J R Chen, B J Gu, L P Dao, et al.
British Journal of Haematology|October 29, 1998
B-cell chronic lymphocytic leukaemia with CD8 expression: report of 10 cases and immunochemical analysis of the CD8 antigenS P Mulligan, L P Dao, S E Francis, et al.
British Journal of Haematology|July 1, 1995
The myelodysplastic syndromes: an analysis of prognostic factors in 226 cases from a single institutionI Cunningham, S J MacCallum, M D Nicholls, et al.
Blood Cancer Journal|February 4, 2017
Ibrutinib in previously treated chronic lymphocytic leukemia patients with autoimmune cytopenias in the RESONATE studyM Montillo, S O'Brien, A Tedeschi, et al.
Leukemia|June 9, 2017
Extended follow-up and impact of high-risk prognostic factors from the phase 3 RESONATE study in patients with previously treated CLL/SLLJ R Brown, P Hillmen, S O'Brien, et al.
Pageof 2